Document is current

Article History

Received: 12 January 2026

Accepted: 14 January 2026

First Online: 10 March 2026

Declarations

:

: Ferrán Losa has acted in an advisory or consultancy role for Amgen and Roche; has participated in a speaker bureau for Amgen, Merck, Roche, Sanofi, and Servier; and has received travel/accommodation fees or expenses from Amgen, Merck, Roche, and Sanofi. Olatz Etxaniz has acted in an advisory or consultancy role for Ipsen, Merck, Pfizer, and Roche; has participated in a speaker bureau for BMS, Ipsen, and Pfizer; and has received expenses from BMS, Clovis, Janssen, and Pfizer. Alejandra Giménez has acted in an advisory or consultancy role for Ipsen; has participated in a speaker bureau for Ipsen, Merck, and Sanofi; and has received expenses from Amgen, Merck, and Roche. Lara Iglesias has acted in an advisory or consultancy role for Bayer, BMS, Lilly, MSD, Roche, and Sanofi; and has participated in a speaker bureau for Bayer, BMS, Eisai, Kyowa-kirin, Merck, MSD, Roche, and Sanofi. Federico Longo has acted in an advisory or consultancy role for Ferre and Roche. Esteban Nogales has acted in an advisory or consultancy role for Daiichi Sankyo and Roche; and has received speaking fees from AstraZeneca, Kyowa Kirin, Pfizer, and Roche. Gemma Soler has acted in an advisory or consultancy role for Amgen, Kiowa, and Roche; has participated in a speaker bureau for Amgen, Merck, Roche, Sanofi, and Servier; and has received travel/accommodation fees or expenses for Amgen, Merck, Roche, and Sanofi. Isaura Fernández has acted in an advisory or consultancy role for AstraZeneca and Roche; and has participated in a speaker bureau for AstraZeneca, Clovis, Glaxo, MSD, Pfizer, and Roche. Paula Gomila and Antonio Sánchez have nothing to disclose.

: Not applicable.

: The manuscript does not contain clinical studies or patient data.